Internal Medicine, Medical Oncology · Saint Peters, MO
NPI
1730352014
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
150 Entrance Way, Div Im Medical Oncology, Ste 100
Saint Peters, MO, 63376
Phone (800) 647-2098
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
94,647 services
Medicare patients, 2024
466
Average age 73
Drug cost, 2024
$1.8M
2,328 prescriptions
Company payments, 2025
$2,991
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley E Frith was code Q5101 (injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram), 10,140 times for 12 patients. In total Ashley E Frith billed 94,647 services in 141 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 10,140 | 12 | $0.27 | $2,786 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 6,200 | 14 | $44.12 | $274K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 3,600 | 15 | $0.11 | $379 |
| J0897 Injection, denosumab, 1 mg | Office | 2,640 | 21 | $18.81 | $50K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2,360 | 20 | $38.66 | $91K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 872 | 39 | $0.09 | $79.69 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 640 | 29 | $0.73 | $465 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 420 | 21 | $0.27 | $114 |
| 99214 Office E&M - Established | Office | 280 | 136 | $92.70 | $26K |
| 96413 Chemotherapy Administration | Office | 246 | 94 | $89.90 | $22K |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 228 | 11 | $59.23 | $14K |
| 96375 Injection Administration | Office | 205 | 60 | $10.95 | $2,245 |
| 96372 Injection Administration | Office | 182 | 71 | $9.81 | $1,785 |
| 96367 Intravenous Infusion, Hydration | Office | 126 | 44 | $20.61 | $2,596 |
| 99213 Office E&M - Established | Office | 112 | 95 | $59.28 | $6,640 |
By year: 2022 $4.2M for 245,771 services; 2023 $3.4M for 213,310 services; 2024 $2.1M for 94,647 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashley E Frith prescribed most often to Medicare patients was Letrozole, with 763 prescriptions and refills. In total Ashley E Frith wrote 2,328 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 763 | 1,627 | 188 | $14K |
| Anastrozole Generic | 188 | 449 | 49 | $2,233 |
| Exemestane Generic | 93 | 197 | 30 | $16K |
| Xarelto Rivaroxaban | 71 | 89 | Under 11 | $51K |
| Tamoxifen Citrate Generic | 69 | 147 | 18 | $1,618 |
| Prochlorperazine Maleate Generic | 67 | 67 | 31 | $1,246 |
| Dexamethasone Generic | 65 | 65 | 18 | $594 |
| Gabapentin Generic | 61 | 69 | Under 11 | $737 |
| Ondansetron Hcl Generic | 54 | 54 | 32 | $350 |
| Oxybutynin Chloride Generic | 45 | 97 | 11 | $536 |
| Eliquis Apixaban | 44 | 64 | Under 11 | $37K |
| Ibrance Palbociclib | 44 | 44 | Under 11 | $730K |
| Escitalopram Oxalate Generic | 42 | 72 | Under 11 | $373 |
| Duloxetine Hcl Generic | 42 | 51 | 13 | $304 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 40 | 40 | 15 | $1,139 |
Brand drugs: 266 claims; generic drugs: 2,062 claims; opioid claims: 103.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley E Frith $2,991 ($2,991 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,976.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.